>
pdufa.bio

Lifileucel plus

Updated ยทnext FDA decision on the calendar

Lifileucel plus is a Iovance Biotherapeutics, Inc. program. Its next catalyst is a Readout in Apr 2027. Every date links its source.

IOVA catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Iovance Biotherapeutics, Inc. (IOVA). We track 3 catalyst events for this program: 2 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jul 2026IOVAReadout · Apr 2027IOVAReadout · Nov 2027IOVA

Questions

When is Lifileucel plus's next FDA decision or readout?

The next tracked catalyst for Lifileucel plus is a Readout in Apr 2027.

What happened at Lifileucel plus's most recent FDA decision?

No FDA decision for Lifileucel plus is in our archive yet.

Who makes Lifileucel plus?

Iovance Biotherapeutics, Inc. (IOVA).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.